Search research articles
Contact Us
Filters
Showing results (91-100 of 140) with videos related to
Page
of 14
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Kampanols: novel Ras farnesyl-protein transferase inhibitors from Stachybotrys kampalensis
S B Singh, D L Zink, M Williams, et al.
Health Affairs (Project Hope)
|
October 3, 2022
Excluding People With Disabilities From Clinical Research: Eligibility Criteria Lack Clarity And Justification
Willyanne DeCormier Plosky, Ari Ne'eman, Benjamin C Silverman, et al.
Nature Medicine
|
October 21, 2022
Supported decision-making can advance clinical research participation for people with disabilities
Benjamin C Silverman, Ari Ne'eman, David H Strauss, et al.
NPP - Digital Psychiatry and Neuroscience
|
April 8, 2026
Advancing neurotech justice in youth digital mental health: insights from an interdisciplinary and cross-generational workshop
Craig W McFarland, Donnella S Comeau, Sepideh Abdi, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1991
Immunization of owl monkeys with a recombinant protein containing repeated epitopes of a Plasmodium falciparum glycophorin-binding protein
N E Aronson, C Silverman, G F Wasserman, et al.
Biochemical and Biophysical Research Communications
|
March 17, 1997
Oreganic acid, a potent inhibitor of ras farnesyl-protein transferase
K C Silverman, H Jayasuriya, C Cascales, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 18, 2003
Four novel bis-(naphtho-gamma-pyrones) isolated from Fusarium species as inhibitors of HIV-1 integrase
Sheo B Singh, Deborah L Zink, Gerald F Bills, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1992
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy
L F Fries, D M Gordon, R L Richards, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1994
Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant
S L Hoffman, R Edelman, J P Bryan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1996
Isolation of a neutralizing human RSV antibody from a dominant, non-neutralizing immune repertoire by epitope-blocked panning
P Tsui, M A Tornetta, R S Ames, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 140) with videos related to
Sort By:
Page
of 14
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Kampanols: novel Ras farnesyl-protein transferase inhibitors from Stachybotrys kampalensis
S B Singh, D L Zink, M Williams, et al.
Health Affairs (Project Hope)
|
October 3, 2022
Excluding People With Disabilities From Clinical Research: Eligibility Criteria Lack Clarity And Justification
Willyanne DeCormier Plosky, Ari Ne'eman, Benjamin C Silverman, et al.
Nature Medicine
|
October 21, 2022
Supported decision-making can advance clinical research participation for people with disabilities
Benjamin C Silverman, Ari Ne'eman, David H Strauss, et al.
NPP - Digital Psychiatry and Neuroscience
|
April 8, 2026
Advancing neurotech justice in youth digital mental health: insights from an interdisciplinary and cross-generational workshop
Craig W McFarland, Donnella S Comeau, Sepideh Abdi, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1991
Immunization of owl monkeys with a recombinant protein containing repeated epitopes of a Plasmodium falciparum glycophorin-binding protein
N E Aronson, C Silverman, G F Wasserman, et al.
Biochemical and Biophysical Research Communications
|
March 17, 1997
Oreganic acid, a potent inhibitor of ras farnesyl-protein transferase
K C Silverman, H Jayasuriya, C Cascales, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 18, 2003
Four novel bis-(naphtho-gamma-pyrones) isolated from Fusarium species as inhibitors of HIV-1 integrase
Sheo B Singh, Deborah L Zink, Gerald F Bills, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1992
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy
L F Fries, D M Gordon, R L Richards, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1994
Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant
S L Hoffman, R Edelman, J P Bryan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1996
Isolation of a neutralizing human RSV antibody from a dominant, non-neutralizing immune repertoire by epitope-blocked panning
P Tsui, M A Tornetta, R S Ames, et al.
Page
of 14